HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Conor C Lynch Selected Research
Conor C Lynch Research Topics
Disease
31
Neoplasms (Cancer)
01/2023 - 12/2002
16
Neoplasm Metastasis (Metastasis)
04/2021 - 12/2002
11
Prostatic Neoplasms (Prostate Cancer)
01/2023 - 05/2014
7
Breast Neoplasms (Breast Cancer)
04/2021 - 08/2008
5
Carcinogenesis
10/2020 - 12/2002
2
Bone Diseases (Bone Disease)
01/2023 - 06/2019
2
Disease Progression
02/2021 - 01/2018
2
Multiple Myeloma
01/2021 - 06/2017
2
Osteolysis
01/2021 - 08/2009
2
Osteosarcoma (Osteogenic Sarcoma)
11/2020 - 11/2015
2
Colonic Neoplasms (Colon Cancer)
06/2004 - 02/2004
1
Spontaneous Fractures (Pathological Fracture)
01/2023
1
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018
1
Hematologic Neoplasms (Hematological Malignancy)
01/2017
1
Adenoma (Adenomas)
06/2004
Drug/Important Bio-Agent (IBA)
11
Matrix Metalloproteinases (MMPs)
IBA
10/2020 - 12/2002
4
Diphosphonates (Bisphosphonates)
IBA
01/2023 - 05/2014
4
Cytokines
IBA
01/2023 - 01/2011
4
Peptide Hydrolases (Proteases)
FDA Link
06/2018 - 01/2010
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
10/2020 - 01/2011
3
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
06/2018 - 01/2017
3
Luciferases
IBA
09/2014 - 01/2006
3
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
04/2010 - 08/2008
2
Androgens
IBA
02/2021 - 01/2019
2
Matrix Metalloproteinase 13
IBA
01/2021 - 01/2012
2
Matrix Metalloproteinase Inhibitors
IBA
10/2020 - 06/2017
2
Conditioned Culture Media
IBA
10/2020 - 09/2011
2
Enzymes
IBA
05/2015 - 08/2008
2
Matrix Metalloproteinase 7 (Matrilysin)
IBA
08/2009 - 07/2007
1
Antigens
IBA
01/2023
1
Immune Checkpoint Inhibitors
IBA
01/2023
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2023
1
EphA2 Receptor
IBA
04/2021
1
Interleukin-6 (Interleukin 6)
IBA
04/2021
1
Prednisone (Sone)
FDA Link
Generic
02/2021
1
Abiraterone Acetate
IBA
02/2021
1
Prostate-Specific Antigen (Semenogelase)
IBA
02/2021
1
Docetaxel (Taxotere)
FDA Link
01/2021
1
Panobinostat
IBA
11/2020
1
romidepsin (FK228)
FDA Link
11/2020
1
Histone Deacetylases (Histone Deacetylase)
IBA
11/2020
1
Histones (Histone)
IBA
11/2020
1
Histone Deacetylase Inhibitors
IBA
11/2020
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
10/2020
1
Chimeric Antigen Receptors
IBA
12/2019
1
betaglycan (TGFBR3)
IBA
10/2019
1
Parathyroid Hormone-Related Protein
IBA
06/2019
1
Vasopressin Receptors (Arginine Vasopressin Receptor)
IBA
01/2019
1
Proteins (Proteins, Gene)
FDA Link
01/2017
1
Phosphotransferases (Kinase)
IBA
01/2017
1
Collagen Type I (Type I Collagen)
IBA
01/2017
1
Zoledronic Acid (Zometa)
FDA Link
01/2017
1
(+)-JQ1 compound
IBA
01/2017
1
Drug Combinations
IBA
11/2015
1
Prodrugs
IBA
12/2014
1
salicylhydroxamic acid (SHAM)
IBA
09/2014
1
Caspase 3 (Caspase-3)
IBA
01/2012
1
A-factor (Streptomyces)
IBA
01/2012
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2012
1
Agar
IBA
01/2012
1
Interleukin-8B Receptors
IBA
09/2011
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
04/2010
1
Cadherins (E-Cadherin)
IBA
01/2010
1
Apolipoproteins D (Apo D)
IBA
05/2005
1
Cathepsin K
IBA
05/2005
1
ErbB Receptors (EGF Receptor)
IBA
06/2004
1
Epidermal Growth Factor (EGF)
IBA
06/2004
Therapy/Procedure
14
Therapeutics
04/2021 - 05/2014
2
Drug Therapy (Chemotherapy)
02/2021 - 06/2018
2
Castration
01/2019 - 01/2015
2
Bioreactors (Bioreactor)
08/2008 - 01/2006
1
Cell Transplantation
01/2018
1
Euthanasia (Mercy Killing)
09/2014
1
Precision Medicine
05/2014
1
Investigational Therapies (Experimental Therapy)
05/2014
1
Intravenous Administration
02/2004